[Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
The long-term effects of citrate therapy (CG-120, 3 g/day or 4 g/day) were examined in 398 patients with upper urinary tract calculi. We studied the influence of citrate therapy on urinary and blood biochemistry in 353 of them. CG-120 caused a sustained increase in urinary citrate, urinary pH and potassium, but no substantial or significant changes in other urinary parameters (uric acid, phosphate, oxalate, sodium, chloride and urine volume). Although urinary calcium decreased significantly up to the 24th week, it did not change significantly there after and it tended to increase at the 54th week. Urinary creatinine excretion decreased after 34 weeks of administration, but this phenomenon could not be explained, because the level of blood urea nitrogen and serum creatinine was not elevated in any case before administration. There were no changes in the serum calcium, magnesium, phosphate, uric acid, sodium, potassium or chloride level.
D001774:Blood Chemical Analysis; D002118:Calcium / Q000652:urine; D002951:Citrates / Q000008:administration & dosage / Q000627:therapeutic use* / Q000652:urine; D019343:Citric Acid; D003404:Creatinine / Q000652:urine; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007669:Kidney Calculi / Q000097:blood / Q000188:drug therapy / Q000652:urine*; D015337:Multicenter Studies as Topic; D011188:Potassium / Q000652:urine; D014514:Ureteral Calculi / Q000097:blood / Q000188:drug therapy / Q000652:urine*
D002951:Citrates; D019343:Citric Acid; D003404:Creatinine; D011188:Potassium; D002118:Calcium